Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,107 public trials 2,039 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921

NCT03298061

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +13 more
Locations: GSK Investigational Site Denver, Colorado, United States

GSK Investigational Site Bethesda, Maryland, United States

GSK Investigational Site Boston, Massachusetts, United States

GSK Investigational Site Boston, Massachusetts, United States

View all 32 locations

View Trial Details

Completed

Copper 64Cu-DOTA-Daratumumab Positron Emission Tomography in Diagnosing Patients With Relapsed Multiple Myeloma

NCT03311828

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

Neurocognitive and Neuroimaging Outcomes in Older Patients With Multiple Myeloma Treated With Autologous Stem Cell Transplantation

NCT03508765

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Rutgers University - Data Analysis New Brunswick, New Jersey, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Implant-based Breast Reconstruction and Mastectomy With Fat Grafting After Breast Conserving Surgery and Radiotherapy

NCT06119633

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +12 more
Locations: Morgagni Pierantoni Hospital Forlì, Italy

Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy

View Trial Details

Completed

A Case Crossover Study of Intermittent Fasting in CLL/SLL

NCT05708326

Conditions: Behavior, Chronic Disease, Chronic Lymphocytic Leukemia (CLL), +19 more
Locations: Eleah Stringer Victoria, British Columbia, Canada

View Trial Details

Completed

TT52CAR19 Therapy for B-cell Acute Lymphoblastic Leukaemia (B-ALL)

NCT04557436

Conditions: B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +19 more
Locations: Great Ormond Street Hospital London, United Kingdom

View Trial Details

Completed

Brentuximab Vedotin Combined With Bendamustine Supercharge, a Low-toxicity and Efficient Salvage Regimen for Primary Refractory or First-relapsed Classic Hodgkin Lymphoma: Long-term Results of a Retrospective Monocenter Study.

NCT06295211

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations: Not specified

View Trial Details

Completed

HMPL-689 Drug Interaction Study With CYP3A Inhibitor/CYP2C9 Inhibitor/CYP3A Inducer/PPI

NCT05602597

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: QPS- Miami Miami, Florida, United States

View Trial Details

Completed

Study of Safety and Efficacy of KTE-C19 in Combination With Atezolizumab in Adults With Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

NCT02926833

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: City of Hope Duarte, California, United States

Stanford Cancer Center Palo Alto, California, United States

H Lee Moffitt Cancer Center Tampa, Florida, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

COVID-19 Infection and Multiple Myeloma

NCT04492371

Conditions: Blood Protein Disorders, COVID-19, Cardiovascular Diseases, +26 more
Locations: General Hopspital Vienna/Medical University Vienna, Austria

UCL Saint-Luc Brussels, Belgium

University Hospital Ostrava Ostrava, Czechia

University Hospital Würzburg Würzburg, Germany

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions